Organization · Venture Capital
SeedtoB Capital
SeedtoB Capital is a venture capital firm based in the United States that invests in early-stage healthcare technology companies, particularly those utilizing artificial intelligence. Founded by experienced entrepreneurs, the firm focuses on supporting diverse founding teams and scalable business models.
Overview
What SeedtoB Capital does
What SeedtoB Capital is
SeedtoB Capital is a venture capital firm based in the United States that invests in early-stage healthcare technology companies, particularly those utilizing artificial intelligence. Founded by experienced entrepreneurs, the firm focuses on supporting diverse founding teams and scalable business models.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- March 7, 2026
Official channels
Find SeedtoB Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
SeedtoB Capital as a funder
Investment thesis
SeedtoB Capital focuses on investing in early-stage healthcare technology companies, particularly those leveraging artificial intelligence to deliver clinical and community impact. They aim to support diverse founding teams from underrepresented geographies in navigating the challenges of building scalable digital health businesses.
Focus narrative
SeedtoB Capital invests between $500,000 and $1,500,000 in innovative healthcare technology companies that have achieved early product-market fit, with a focus on those generating annual recurring revenue of $500,000 or more. They prioritize scalable business models that utilize differentiated technology, especially artificial intelligence, and emphasize support for diverse founding teams from underrepresented geographies.
Value beyond capital
SeedtoB Capital provides value to its portfolio companies through deep operational expertise in healthcare AI, helping founders anticipate and navigate challenges. Their unique background as operator-founders allows them to offer tailored support, ensuring that companies can efficiently progress from seed to Series B.
Terms and economics
- Typical check
- $500,000–$1,500,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
SeedtoB Capital's portfolio includes notable companies such as: AngelEye Health: Specializes in pediatric technology and secured a $9 million investment. Tern Group: Recently raised $24 million in Series A funding, focusing on AI workforce infrastructure. Biotia: Developed an advanced 'Test-to-Treat' platform for recurrent urinary tract infections and partnered with HSS for diagnostics. Moonlight Therapeutics: Received FDA approval for a peanut allergy drug trial. Scripta Insights: Expanded provider engagement and launched Spanish language support.
Common questions
What to know about SeedtoB Capital
Upseed classifies SeedtoB Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 7, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.